The aim of this study is to investigate the routine blood parameters of COVID-19 patients at the time of admission to the emergency department and their relationship with the severity of the disease and prognosis. A total of 500 patients, who were diagnosed with severe COVID-19 and hospitalized in the intensive care unit between 01.04.2020 and 01.02.2021 in the emergency department of a pandemic hospital, were retrospectively analyzed. Demographic, clinical, and laboratory data of the patients were obtained from the hospital registry system. Neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) were calculated using neutrophil, lymphocyte, monocyte, and platelet counts. These patients were divided into two groups: survivors and deceased. All parameters obtained from routine blood analysis were statistically compared between these two groups. While 280 out of 500 patients survived, 220 died. Of all patients, the mean age was 67 years and 51.8% were males. There was a significant difference between the two groups in terms of age, gender, length of hospital stay, need for mechanical ventilation, white blood cell, neutrophil, lymphocyte, monocyte, eosinophil, platelet counts, CRP, ferritin, procalcitonin values, NLR, MLR, and PLR ( for all). While NLR alone and MLR + NEU and NLR + PLR + MLR combinations had the highest AUC values (0.930, 0.947, and 0.939, respectively), MLR and PLR alone showed the lowest AUC values (0.875 and 0.797, respectively). The sensitivity, specificity, positive predictive values (PPVs), and negative predictive values (NPVs) in the prediction of death according to the cutoff values of the parameters have been determined. A significant correlation was determined between age, NLR, MLR, and PLR and duration of hospital stay ( for all). Routine blood parameters and NLR, MLR, and PLR can assist emergency physicians to identify the severity and early prognosis of COVID-19 patients.
Aim: The study investigated heparin-binding protein (HBP) levels in patients with severe COVID-19 pneumonia and their relation to prognosis. Methods: A total of 134 patients with serious COVID-19 p...
Graves’ disease (GD) is an autoimmune thyroid disorder characterized by excessive thyroid hormone production driven by thyroid-stimulating hormone (TSH) receptor antibodies (TRAb). This study aimed to investigate the relationship between serum spexin (SPX) levels, TRAb levels, thyroid ultrasound findings, and metabolic parameters in GD patients while evaluating SPX as a potential biomarker for autoimmune inflammation. A prospective, single-center study included 45 GD patients and 45 healthy controls. Serum TSH, free T3, free T4, anti-thyroglobulin, antithyroid peroxidase, TRAb, and SPX levels were measured. Thyroid ultrasonography classified patients into mild, moderate, and high heterogeneity groups. SPX levels were significantly higher in GD patients compared to controls (p < 0.001) and showed a strong positive correlation with TRAb levels (r = 0.579, p < 0.001) and thyroid heterogeneity (p < 0.001). Newly diagnosed patients (<6 months) exhibited the highest SPX levels, which decreased with prolonged disease duration. Receiver operating characteristic analysis identified a cutoff value of 105 pg/mL for SPX, yielding 60% sensitivity and 91.1% specificity (area under the curve: 0.765, p < 0.001). SPX levels were also inversely correlated with disease duration and positively associated with inflammatory markers, suggesting its utility in monitoring disease activity and progression. These findings highlight SPX as a novel biomarker for assessing disease severity and autoimmune inflammation in GD. Incorporating SPX measurements into clinical practice may aid in early diagnosis, disease stratification, and therapeutic monitoring, ultimately improving personalized care for GD patients.
1 March 2015 in Hong Kong Journal of Emergency Medicine
Background/aim: This study evaluated the accuracy rates and response consistency of four different large language models (ChatGPT- 4o, Gemini 2.0, Claude 3.5, and DeepSeek R1) in answering questions from the Emergency Medicine Fellowship Examination (YDUS), which was administered for the first time in Türkiye. Materials and methods: In this observational study, 60 multiple-choice questions from the Emergency Medicine YDUS administered on 15 December 2024, were classified as knowledge-based (n = 26), visual content (n = 2), and case-based (n = 32). Each question was presented three times to the four large language models. The models’ accuracy rates were evaluated according to overall accuracy, strict accuracy, and ideal accuracy criteria. Response consistency was measured using Fleiss’ Kappa test. Results: The ChatGPT-4o model was the most successful in terms of overall accuracy (90.0%), while DeepSeek R1 showed the lowest performance (76.7%). Claude 3.5 (83.3%) and Gemini 2.0 (80.0%) demonstrated moderate success. When analyzed by category, ChatGPT-4o achieved the highest success with 92.3% accuracy in knowledge-based questions and 90.6% in case-based questions. In terms of response consistency, the Claude 3.5 model (Fleiss’ Kappa = 0.68) showed the highest consistency, while Gemini 2.0 (Fleiss’ Kappa = 0.49) showed the lowest. Inconsistent hallucinations were more frequent in the Gemini 2.0 and DeepSeek R1 models, whereas persistent hallucinations were less common in the ChatGPT-4o and Claude 3.5 models. Conclusion: Large language models can achieve high accuracy rates for knowledge and clinical reasoning questions in emergency medicine but show differences in terms of response consistency and hallucination tendency. While these models have significant potential for use in medical education and as clinical decision support systems (CDSS), they need further development to provide reliable, up-to-date, and accurate information.
About Me
Mehmet Yortanlı, MD, is an Emergency Medicine specialist currently working at Konya Numune Hospital, Department of Emergency Medicine, Konya, Turkey. He received his medical degree from Ege University Faculty of Medicine in 2011 and completed his specialty training in Emergency Medicine at Konya Training and Research Hospital. In 2024, he graduated from Istanbul University, Open and Distance Education Faculty (AUZEF), Computer Programming Program. His clinical practice focuses on emergency and critical care, including sepsis, acute intoxications, trauma, and the management of critically ill patients. His research interests include prognostic biomarkers in emergency settings, sepsis and inflammatory response, acute pancreatitis, gastrointestinal bleeding, lactate-based predictive models, and clinical risk scoring systems. He also has a strong interest in medical data analysis, biostatistics, and the application of artificial intelligence and large language models in emergency medicine, radiology, and clinical decision support systems. Dr. Yortanlı is a member of national emergency medicine societies and continues to pursue translational research integrating clinical medicine with data science and computational approaches.
Mehmet Yortanlı, MD, is an Emergency Medicine specialist currently working at Konya Numune Hospital, Department of Emergency Medicine, Konya, Turkey. He received his medical degree from Ege University Faculty of Medicine in 2011 and completed his specialty training in Emergency Medicine at Konya Training and Research Hospital. In 2024, he graduated from Istanbul University, Open and Distance Education Faculty (AUZEF), Computer Programming Program. His clinical practice focuses on emergency and critical care, including sepsis, acute intoxications, trauma, and the management of critically ill patients. His research interests include prognostic biomarkers in emergency settings, sepsis and inflammatory response, acute pancreatitis, gastrointestinal bleeding, lactate-based predictive models, and clinical risk scoring systems. He also has a strong interest in medical data analysis, biostatistics, and the application of artificial intelligence and large language models in emergency medicine, radiology, and clinical decision support systems. Dr. Yortanlı is a member of national emergency medicine societies and continues to pursue translational research integrating clinical medicine with data science and computational approaches.